Any immune disorder increases the risk of SARS-CoV-2virus and COVID-19 illness. The most prevalent immune disease is diabetes. Type 2 diabetes and obesity have increased worldwide to epidemic proportions and, together, are deadly contributors to the COVID-19 pandemic. Obesity and type 2 diabetes also are important factors in the management of chronic pain disorders.
Controlling type 1 and type 2 diabetes is the most effective way to prevent diabetic neuropathy. When treatments are needed, however, there are a number of promising options.
Eight months ago, a patient developed diabetic neuropathy. He is now complaining of a severe burning sensation, pain, and numbness in both lower limbs. He currently is taking pregabalin (Lyrica) at 150 mg bid and duloxetine at 60 mg bid.
Assessment of neuropathic pain begins with a thorough neurologic history, addressing the nature and onset of pain symptoms and underlying etiologic factors.
Peripheral artery disease is common in patients with diabetes. Proper prevention and early diagnosis can help patients avoid painful neuropathies and lower-extremity amputations.
In an open-label trial, a unique electric current combined with a local anesthetic reduced pain in patients who have diabetic neuropathy. Read up on the results in this neuropathy research study.
Diabetic neuropathy is a common complication of type 1 diabetes and type 2 diabetes, associated with duration of the disease and duration of hyperglycemia. Article covers treating the painful symptoms of diabetic neuropathy.
Diabetes mellitus is the leading cause of peripheral neuropathy. This article focuses on the epidemiology and pathogenesis as well as clinical features, diagnosis, and management of DSPN, the most common form of diabetic neuropathy.
Pain management challenge in diagnosing and treating a rare case of phrenic nerve palsy in combination with cervical facet joint pain in a diabetic patient.